Pills from the literature
-
Early-life lower respiratory tract infection: Addressing Long-Term Health Risks through Nutritional Interventions and Public Awareness
-
Omalizumab: a definitive cure for food allergies?
-
Association between atopic dermatitis and school readiness in preschool children
-
Risk of second allergic reaction to SARS-CoV-2 vaccines: a systematic review and meta-analysis
-
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study
-
Long COVID-19 in children: from the pathogenesis to the biologically plausible roots of the syndrome
-
Prevenzione delle allergie alimentari nella prima infanzia: le raccomandazioni EAACI 2020
-
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: an ARIA-EAACI-GA2LEN consensus
-
Pathogenesis of IgE-mediated food allergy and implications for future immunotherapeutics